Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1350697rdf:typepubmed:Citationlld:pubmed
pubmed-article:1350697lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C0242531lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C0332162lld:lifeskim
pubmed-article:1350697lifeskim:mentionsumls-concept:C2926735lld:lifeskim
pubmed-article:1350697pubmed:issue4lld:pubmed
pubmed-article:1350697pubmed:dateCreated1992-7-2lld:pubmed
pubmed-article:1350697pubmed:abstractTextThe onset and duration of action of vecuronium were studied in young adult (n = 30; mean age 34 +/- 11.1 (s.d.) yr), middle-aged (n = 20; mean age 60 +/- 5.8 yr) and elderly patients (n = 30; mean age 80 +/- 4.6 yr) anaesthetised with thiopentone, nitrous oxide in oxygen and halothane. Neuromuscular block was monitored by applying the train-of-four (TOF) stimulation at 2 Hz to the ulnar nerve every 12 s. Half the patients in each group received 0.08 and the other half 0.12 mg kg-1 of the relaxant. The time to return of T1 (first response in the TOF sequence) to 25% of control was 28 +/- 5.2 (s.d.), 34 +/- 7.1 and 39 +/- 10.2 min following 0.08 mg kg-1 dose (P less than 0.05 between the elderly and young adults) and 45 +/- 9.2, 48 +/- 6.2 and 69 +/- 19.2 min following 0.12 mg kg-1 dose, respectively, in the three age groups (P less than 0.05 between the elderly and the other two groups). The recovery indices (time for 25-75% recovery of T1) after the 0.08 mg kg-1 was 9.6 +/- 3.4, 13.6 +/- 5.1 and 17.4 +/- 6.1 min, respectively (P less than 0.05 between the elderly and young adults). There was no significant difference in any of the parameters between the young adults and the middle-aged. The onset of block at each dose was not significantly different between the three age groups; however, the time to maximum effect was significantly shorter with the higher dose in the young and the middle-aged, but not in the elderly. Regression analysis of the data between age and the duration of action and recovery index suggested a significant prolongation (P less than 0.05) of these parameters in the elderly.lld:pubmed
pubmed-article:1350697pubmed:languageenglld:pubmed
pubmed-article:1350697pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1350697pubmed:citationSubsetIMlld:pubmed
pubmed-article:1350697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1350697pubmed:statusMEDLINElld:pubmed
pubmed-article:1350697pubmed:monthMaylld:pubmed
pubmed-article:1350697pubmed:issn0001-5172lld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:ClarkeR SRSlld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:McCarthyGGlld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:CooperRRlld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:MirakhurR KRKlld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:ElliottPPlld:pubmed
pubmed-article:1350697pubmed:authorpubmed-author:SharpeT DTDlld:pubmed
pubmed-article:1350697pubmed:issnTypePrintlld:pubmed
pubmed-article:1350697pubmed:volume36lld:pubmed
pubmed-article:1350697pubmed:ownerNLMlld:pubmed
pubmed-article:1350697pubmed:authorsCompleteYlld:pubmed
pubmed-article:1350697pubmed:pagination383-6lld:pubmed
pubmed-article:1350697pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:meshHeadingpubmed-meshheading:1350697-...lld:pubmed
pubmed-article:1350697pubmed:year1992lld:pubmed
pubmed-article:1350697pubmed:articleTitleOnset and duration of action of vecuronium in the elderly: comparison with adults.lld:pubmed
pubmed-article:1350697pubmed:affiliationDepartment of Anaesthetics, Queen's University, Belfast, N. Ireland.lld:pubmed
pubmed-article:1350697pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1350697pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1350697pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed